Cleveland Clinic, Cleveland, OH 44195, USA.
Europace. 2013 Nov;15(11):1669-76. doi: 10.1093/europace/eut144. Epub 2013 Jun 4.
Cryoballoon ablation is an emerging therapy for atrial fibrillation (AF). However, the Arctic Front cryoballoon (Medtronic) cannot be localized on current electroanatomic mapping (EAM) systems. We describe a technique to visualize guidewires in an impedance-based EAM system.
A novel technique for real-time guidewire localization in an EAM (Ensite Velocity, St Jude Medical) was prospectively evaluated among patients referred for cryoballoon AF ablation. The guidewire was visualized as an 'orb' on the EAM and localization in each of the pulmonary veins (PVs) compared with orthogonal fluoroscopy, contrast venography, and intra-cardiac echocardiography. Application of the technique in 21 consecutive patients [median age 58 (interquartile range 21); 71.4% male; 85.7% paroxysmal AF] demonstrated agreement with respect to guidewire localization in 82 of 82 (100%) PVs. Discrimination of guidewire position in the left atrial appendage from the left PVs was also demonstrated. When compared with 21 consecutive cryoballoon procedures over the same time period in which the technique was not used, fluoroscopy time was reduced [median 53.2 (25.9) vs. 72.3 (47.6) min, P = 0.008], and a trend towards reduced radiation exposure [median 372 (656.0) vs. 581 (849.9) mGy, P = 0.08] was noted, without effect on acute procedural or mid-term endpoints. Ex vivo assessment of the technique in a saline bath left atrial model demonstrated that the 'orb' localizes to the centroid of the exposed portion of the guidewire.
This simple, novel technique provides real-time, accurate guidewire localization to enable guidewire and catheter navigation during cryoballoon AF ablation.
冷冻球囊消融术是一种治疗心房颤动(房颤)的新兴疗法。然而,美敦力公司生产的 Arctic Front 冷冻球囊无法在现有的电生理标测系统上定位。我们描述了一种在基于阻抗的电生理标测系统上可视化导丝的技术。
我们前瞻性地评估了一种新的实时导丝定位技术在电生理标测系统(圣犹达医疗公司的 Ensite Velocity)中的应用,该技术适用于接受冷冻球囊房颤消融治疗的患者。导丝在电生理标测上显示为一个“球”,与正交透视、对比静脉造影和心腔内超声相比,可在每个肺静脉(PV)中定位。该技术在 21 例连续患者中的应用[中位年龄 58(25-79)岁;71.4%为男性;85.7%为阵发性房颤]中,82 个(100%)PV 中的导丝定位均得到了很好的验证。还证明了该技术可以区分左心耳与左肺静脉之间导丝的位置。与同期未使用该技术的 21 例连续冷冻球囊手术相比,透视时间减少[中位数 53.2(25.9)比 72.3(47.6)min,P=0.008],辐射暴露有减少的趋势[中位数 372(656.0)比 581(849.9)mGy,P=0.08],但对急性手术或中期终点无影响。在盐水浴左心房模型中的体外评估表明,“球”定位于暴露导丝的质心。
这项简单、新颖的技术提供了实时、准确的导丝定位,可在冷冻球囊房颤消融术中实现导丝和导管导航。